However, managing treatment-resistant depression often requires ... or oral tablets. “In our center, we’ve seen really incredible results with Spravato and ketamine in general,” Malina said. “We have ...

I specialize in helping individuals with treatment-resistant depression (TRD) by offering Spravato (esketamine) therapy, an FDA-approved breakthrough treatment that provides new hope for those ...

Credit: Johnson & Johnson. The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.

There’s also the chance it could be misused. Because of this, Spravato is only available at certified treatment centers where patients are closely monitored. You won’t be able to pick it up at ...

Meaning, you have to go to a specialty treatment center and use the medication under the supervision of a licensed healthcare provider. After you take Spravato, you have to be observed for at ...

That is one of 3,000 outpatient treatment centers in the U.S. that are certified to administer Spravato, according to J&J's tally. Mattingly said patients can now choose to take Spravato with or ...

The FDA has approved Johnson & Johnson’s (J&J) Spravato (esketamine) CIII nasal spray, marking the first monotherapy to be approved for adults with treatment-resistant depression (TRD). According to ...

"Spravato is now available as a stand-alone treatment, meaning patients may ... more Americans are facing hour-plus drives to reach surgical centers, two new reports find. Diabetes can drive ...